-5%
In type 2 diabetes mellitus patients, (Glimepiride 1mg + Metformin 500mg) complements diet and exercise:
- When glimepiride or metformin alone isn’t effectively controlling blood sugar levels.
- When replacing a combination treatment of glimepiride and metformin.
Losucon M 2/500 SR Tablet is a combination medication containing Glimepiride and Metformin, both belonging to the group of Antidiabetic agents. It’s used for treating type 2 diabetes mellitus when diet, exercise, and a single agent aren’t enough for proper glycemic control. Type 2 diabetes is a chronic condition where the body lacks sufficient insulin or the produced insulin doesn’t function effectively. Symptoms include excessive urination, thirst, hunger, fatigue, and blurred vision.
Glimepiride stimulates insulin production from the pancreas and enhances insulin utilization, thereby lowering blood sugar. Metformin, a biguanide, reduces liver sugar release into the bloodstream. Complementing Losucon M 2/500 SR Table with regular exercise and a prescribed diet plan is advised for optimal results.
Before starting Losucon M 2/500 SR Table, inform your doctor about type 1 diabetes, diabetic ketoacidosis, severe liver or kidney issues, and acute heart problems. Notify if you’re pregnant or breastfeeding. It’s not suitable for children or adolescents under 18 years. Alcohol consumption should be avoided during Losucon M 2/500 SR Table treatment, as it can alter its blood sugar-lowering effects and increase lactic acidosis risk. Common side effects include taste changes, nausea, diarrhea, stomach pain, and vomiting. If symptoms worsen, consult your doctor.